SD Biosensor, Inc (KRX:137310)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,580
-50 (-0.43%)
At close: Jun 5, 2025, 3:30 PM KST
16.27%
Market Cap 1.39T
Revenue (ttm) 703.51B
Net Income (ttm) -105.94B
Shares Out 119.62M
EPS (ttm) -871.90
PE Ratio n/a
Forward PE n/a
Dividend 200.00 (1.73%)
Ex-Dividend Date Dec 27, 2024
Volume 194,143
Average Volume 434,581
Open 11,610
Previous Close 11,630
Day's Range 11,520 - 11,710
52-Week Range 7,870 - 15,340
Beta 0.97
RSI 65.96
Earnings Date May 13, 2025

About SD Biosensor

SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decis... [Read more]

Sector Healthcare
Founded 2010
Employees 576
Stock Exchange Korea Stock Exchange
Ticker Symbol 137310
Full Company Profile

Financial Performance

In 2024, SD Biosensor's revenue was 694.57 billion, an increase of 5.93% compared to the previous year's 655.68 billion. Losses were -98.41 billion, -78.96% less than in 2023.

Financial Statements

News

There is no news available yet.